Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
Thomas F Gajewski, April KS Salama, Donna Niedzwiecki, Jeffrey Johnson, Gerald Linette, Cynthia Bucher, Michelle A Blaskovich, Said M Sebti, Frank HaluskaVolume:
10
Langue:
english
DOI:
10.1186/1479-5876-10-246
Date:
December, 2012
Fichier:
PDF, 290 KB
english, 2012